Oxidative stress: Potential of distinct peroxide determination systems

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 8, 2004, Pages 907-914

  Lindschinger, Meinrad ^a   Nadlinger, Karl ^b   Adelwöhrer, Norbert ^a   Holweg, Karin ^a   Wögerbauer, Markus ^b   Birkmayre, Jörg ^b   Smolle, Karl Heinz ^c   Wonisch, Willibald ^c  

^a Inst for Nutr/Metabolic Diseases   (Austria)

^b Birkmayer Laboratories ^*  (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antioxidants; Lipid peroxidation; ox LDL anti bodies; Oxidative stress; Oxidative stress measurement; Peroxides

Indexed keywords

ANTIOXIDANT; AUTOANTIBODY; HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN;

ADULT; ANALYTIC METHOD; ANTIBODY TITER; ANTIOXIDANT ACTIVITY; ARTICLE; BIOASSAY; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC KIT; DISEASE ASSOCIATION; FEMALE; HEALTH PROGRAM; HUMAN; INTERMETHOD COMPARISON; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL INSTRUMENTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ADULT; ANTIOXIDANTS; AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; LIPID PEROXIDES; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 4444291740     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.147     Document Type: Article

References (59)

1. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128.
2. Schaur RJ. Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 2003;24:149-59.
3. Siems W, Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 2003;24:167-75.
4. Zarkovic N. 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 2003;24:281-91.
5. Esterbauer H. Estimation of peroxidative damage. A critical review. Pathol Biol (Paris) 1996;44:25-8.
6. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44:1309-15.
7. Rice-Evans C, Miller NJ. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994;234:279-93.
8. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996;42:498-506.
9. Lands LC, Grey VL, Grenier C. Total plasma antioxidant capacity in cystic fibrosis. Pediatr Pulmonol 2000;29:81-7.
10. Lantos J, Roth E, Czopf L, Nemes J, Gal I. Monitoring of plasma total antioxidant status in different diseases. Acta Chir Hung 1997;36:188-9.
11. Child RB, Wilkinson DM, Fallowfield JL., Donnelly AE. Elevated serum antioxidant capacity and plasma malondialdehyde concentration in response to a simulated half-marathon run. Med Sci Sports Exerc 1998; 30:1603-7.
12. MacKinnon KL, Molnar Z, Lowe D, Watson ID, Shearer E. Measures of total free radical activity in critically ill patients. Clin Biochem 1999;32:263-8.
13. Winkler R, Griebenow S, Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Funct 2000;18:143-6.
14. Krstevska M, Dzhekova-Stojkova S, Bosilkova G. Menopause, coronary artery disease and antioxidants. Clin Chem Lab Med 2001;39:641-4.
15. Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999;48:1414-7.
16. Napoli C. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies. G Ital Cardiol 1997;27:1302-14.
17. Vaarala O. Antibodies to oxidised LDL. Lupus 2000;9:202-5.
18. Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S. Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol 2001; 37:775-9.
19. Buonocore G, Perrone S, Longini M, Terzuoli L, Bracci R. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies. Pediatr Res 2000;47:221-4.
20. Poli G, Schaur RJ. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. Life 2000;50:315-21.
21. Felley CP, Pignatelli B, Van Melle GD, Crabtree JE, Stolte M, Diezi J, et al. Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication. Helicobacter 2002;7:342-8.
22. Bostan M, Brasoveanu LI, Livescu A, Manda G, Neagu M, Iordachescu D. Effects of synovial fluid on respiratory burst of granulocytes in rheumatoid arthritis. J Cell Mol Med 2001;5:188-94.
23. Niess AM, Dickhuth HH, Northoff H, Fehrenbach E. Free radicals and oxidative stress in exercise - immunological aspects. Exerc Immunol Rev 1999;5:22-56.
24. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 2002;106:1925-9.
25. Festa A, Kopp HP, Menzel EJ. Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 1998;41:350-60.
26. Cesarone MR, Belcaro G, Caratelli M, Cornelli U, De Sanctis MT, Incandela L, et al. A simple assay to monitor oxidative stress. Int Angiol 1999;18:127-30.
27. Elstner EF. Der Sauerstoff: Die biologische OH-Bildung. Mannheim-Wien-Zürich: Wissenschaftsverlag, 1990.
28. Minotti G, Aust SD. The role of iron in the initiation of lipid peroxidation. Chem Phys Lipids 1987;44:191-208.
29. Parmigiani S, Gambini L, Massari A, Pezzani I, Payer C, Bevilacqua G. Evaluation of reactive oxygen metabolites with micromethod in neonates: determination of standards of normality in full-term babies. Acta Biomed Ateneo Parmense 1997;68 Suppl 1:103-6.
30. Digiesi V, Oliviero C, Gianno V, Rossetti M, Fiorillo C, Oradei A, et al. Reactive metabolites of oxygen, lipid peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension. Clin Ter 1997;148:515-9.
31. Tatzber F, Griebenow S, Wonisch W, Winkler R. Dual method for the determination of peroxidase-activity and total peroxides - iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 2003;316:147-53.
32. Schippinger G, Wonisch W, Abuja PM, Fankhauser F, Winklhofer-Roob BM, Halwachs G. Lipid peroxidation and antioxidant status in professional American football players during competition. Eur J Clin Invest 2002;32:686-92.
33. Roob JM, Khoschsorur G, Tiran A, Horina JH, Holzer H, Winklhofer-Roob BM. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000;11:539-49.
34. Tatzber F, Esterbauer H. Autoantibodies to oxidized low density lipoprotein. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, editors. Free radicals IX. London: Richelieu Press, 1995:245-62.
35. Thomas L, Abdelhamid S. Diagnostische Sensitivität und Spezifität. In: Thomas L, editor. Labor und Diagnose, 4th ed. Frankfurt: Medizinische Verlagsgesellschaft Marburg, 1995:1863-4.
36. O'Connell MJ, Peters TJ. Ferritin and haemosiderin in free radical generation, lipid peroxidation and protein damage. Chem Phys Lipids 1987;45:241-9.
37. Hostmark AT, Lystad E, Vellar OD, Hovi K, Berg JE. Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet. Plant Foods Hum Nutr 1993;43:55-61.
38. McLemore JL, Beeley P, Thorton K, Morrisroe K, Blackwell W, Dasgupta A. Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples. Am J Clin Pathol 1998;109:268-73.
39. Szymczyk G, Beltowski J, Marciniak A, Kotarski J. Assessment of serum lipid peroxide levels and antioxidant status in females who had undergone total abdominal hysterectomy without closing of the peritoneum. Ginekol Pol 2003;74:1397-403.
40. Agil A, Fuller CJ, Jialal I. Susceptibility of plasma to ferrous iron/hydrogen peroxide-mediated oxidation: demonstration of a possible Fenton reaction. Clin Chem 1995;41:220-5.
41. Esterbauer H, Benedetti A, Lang J, Fulceri R, Fauler G, Comporti M. Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochim Biophys Acta 1986;876:154-66.
42. 2 production and lipid and protein oxidative damage. Mech Ageing Dev 2001;122:427-43.
43. Gieseg S, Duggan S, Gebicki JM. Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochem J 2000;350:215-8.
44. Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995;48:825-34.
45. Wonisch W, Hayn M, Schaur RJ, Tatzber F, Kranner I, Grill D, et al. Increased stress parameter synthesis in the yeast Saccharomyces cerevisiae after treatment with 4-hydroxy-2-nonenal. FEBS Lett 1997;405:11-5.
46. Prior RL, Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Mad 1999;27:1173-81.
47. Brown S, Georgatos M, Reifel C, Song JH, Shin SH, Hong M. Recycling processes of cellular ascorbate generate oxidative stress in pancreatic tissues in in vitro system. Endocrine 2002;18:91-6.
48. Stocker R. The ambivalence of vitamin E in atherogenesis. Trends Biochem Sci 1999;24:219-23.
49. Bowen HT, Omaye ST. Oxidative changes associated with beta-carotene and alpha-tocopherol enrichment of human low-density lipoproteins. J Am Coll Nutr 1998;17:171-9.
50. Stanger O, Semmelrock HJ, Wonisch W, Bös U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 2002; 303:158-62.
51. Wildburger R, Borovic S, Zarkovic N, Tatzber F. Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins. Wien Klin Wochenschr 2000;112:798-803.
52. Luc G, Fruchart JC. Oxidation of lipoproteins and atherosclerosis. Am J Clin Nutr 1991;53(1 Suppl):206S-9S.
53. Inoue T, Inoue K, Maeda H, Takayanagi K, Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin Chim Acta 2001;305:115-21.
54. Pincemail J, Lecomte J, Castiau JP, Collard E, Vasankari T, Cheramy-Bien JP, et al. Evaluation of autoantibodies against oxidized LDL and antioxidant status in top soccer and basketball players after 4 months of competition. Free Radic Biol Med 2000;28:559-65.
55. Steinerova A, Stozicky F, Racek J, Tatzber F, Zima T, Stetina R. Antibodies against oxidized LDL in infants. Clin Chem 2001;47:1137-8.
56. Shoji T, Nishizawa Y, Fukumoto M, Shimamura K, Kimura J, Kanda H, et al. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects. Atherosclerosis 2000;148:171-7.
57. Strohmaier W, Reiger J, Tatzber F, Wonisch W, Schlag G, Esterbauer H. Septicemic patients show a decrease in neopterin levels and an increase in autoantibodies to oxidized LDL (oLAb) after successful therapeutic intervention. Biofactors 1997;6:279-80.
58. Schumacher M, Eber B, Tatzber F, Kaufmann P, Halwachs G, Fruhwald FM, et al. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction. Free Radic Biol Med 1995;18:1087-91.
59. Winklhofer-Roob BM, Van't Hof MA, Shmerling DH. Reference values for plasma concentrations of vitamin E and A and carotenoids in a Swiss population from infancy to adulthood, adjusted for seasonal influences. Clin Chem 1997;43:146-53.